Edwards Lifesciences Corp (EW)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $61.61B
Last updated: Nov 17, 2026 at 11:06 AM ET
Edwards Lifesciences Corp (EW) P/E Ratio & Valuation History
Edwards Lifesciences (EW) trades at 36.4x trailing earnings and 9.2x sales. Its P/E of 36.4x is above its 5-year median of 31.9x. Its forward P/E is 31.3x. The median P/E across 11 similar companies is 20.0x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 16.3% higher over the next year. Its free cash flow yield is 2.3%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 36.4x |
| Forward P/E | 31.3x |
| Price to sales | 9.2x |
| Price to book | 5.7x |
| EV/EBITDA | 41.7x |
| Price to FCF | 43.3x |
| EV/FCF | 41.6x |
| PEG | 2.4 |
| FCF yield | 2.3% |
Historical Medians
Against its 10-year medians, its P/E is 7.7% above 33.8x, its P/S is 3.2% below 9.5x and its P/B is 32.9% below 8.5x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 36.4x | 31.9x | 33.8x |
| P/S | 9.2x | 8.9x | 9.5x |
| P/B | 5.7x | 6.2x | 8.5x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 28.3x in 2024 to 58.1x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $85.25 | 33.3x | 8.2x | 4.8x |
| 2024 | $74.03 | 28.3x | 8.1x | 4.4x |
| 2023 | $76.25 | 30.4x | 9.2x | 7.0x |
| 2022 | $74.61 | 30.1x | 10.4x | 7.9x |
| 2021 | $129.55 | 58.1x | 15.5x | 14.0x |
| 2020 | $91.23 | 49.3x | 13.0x | 12.6x |
| 2019 | $77.76 | 41.8x | 11.2x | 12.0x |
| 2018 | $51.06 | 32.5x | 8.7x | 10.3x |
| 2017 | $37.57 | 29.8x | 7.0x | 8.1x |
| 2016 | $31.23 | 32.2x | 6.8x | 7.8x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About EW
What is EW's forward P/E ratio?
Edwards Lifesciences has a forward P/E ratio of 31.3x.
Is EW stock overvalued?
GNG's valuation label for EW is Fairly valued. Its P/E of 36.4x compares with a median of 20.0x across 11 similar companies.
What is EW's price to sales ratio?
Edwards Lifesciences has a price to sales ratio of 9.2x.
What is Edwards Lifesciences's average P/E ratio over 5 years?
Edwards Lifesciences's median P/E over the last 5 years is 31.9x, from 60 month-end values through Oct 2026.
What is EW's PEG ratio?
Edwards Lifesciences has a PEG ratio of 2.4.
EW pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts